Suppr超能文献

微卫星不稳定性分析及其与食管病变(包括癌症)中 hMLH1 修复基因甲基化状态的相关性。

Microsatellite instability analysis and its correlation with hMLH1 repair gene hypermethylation status in esophageal pathologies including cancers.

机构信息

Department of Genetics & Molecular Medicine, Kamineni Hospitals, LB Nagar, Hyderabad, India.

出版信息

Cancer Biomark. 2010;7(1):1-10. doi: 10.3233/CBM-2010-0135.

Abstract

Cancer development is associated with genetic instability. Identification of specific loci altered during carcinogenesis in a particular tissue gives scope for early detection and predicting the progressive nature of the tissue pathology. Instability at microsatellite loci is widely attributed to mismatch repair errors due to epigenetic alterations. Using three dinucleotide markers, D3S1313, D9S171, D17S250 and two mononucleotide markers BAT25, BATRII, we evaluated MSI in 97 cases enrolled for endoscopy of upper GI tract with symptoms of dyspepsia, reflux or dysphagia. We aimed at evaluating markers that reflect instability in esophageal malignancies, examine the prevalence of MSI in cancers and other pathologies of the esophagus, and determine the methylation status of hMLH1 gene in relation to MSI. 42% (21/50) cancers and 15.4%(2/13) precancers exhibited MSI where 85.7% cancers and 50% precancers with MSI, showed a hypermethylated hMLH1 promoter. Increased number of cases with repair gene methylation were seen with increasing severity of the esophageal pathology suggesting epigenetic progression parallels histologic changes. BAT25 and D3S1313 markers exhibited instability frequently and cases with MSI using these markers showed an abnormal hMLH1 promoter. Thus these markers were useful in identifying the mismatch repair phenotype. These two markers may be useful to screen cases for early cancer related changes, after validation on a larger sample.

摘要

癌症的发生与遗传不稳定性有关。鉴定特定组织癌变过程中改变的特定基因座,为早期检测和预测组织病理学的进展提供了可能。微卫星不稳定广泛归因于由于表观遗传改变导致的错配修复错误。我们使用三个二核苷酸标记物(D3S1313、D9S171、D17S250)和两个单核苷酸标记物(BAT25、BATRII),对 97 例因消化不良、反流或吞咽困难等上消化道内镜症状就诊的患者进行了微卫星不稳定性(MSI)评估。我们旨在评估反映食管恶性肿瘤不稳定性的标志物,检查食管癌症和其他病变中 MSI 的发生率,并确定与 MSI 相关的 hMLH1 基因的甲基化状态。42%(21/50)的癌症和 15.4%(2/13)的癌前病变表现出 MSI,其中 85.7%的 MSI 癌症和 50%的 MSI 癌前病变显示 hMLH1 启动子高度甲基化。随着食管病变严重程度的增加,修复基因甲基化的病例数量增加,表明表观遗传进展与组织学变化平行。BAT25 和 D3S1313 标记物经常表现出不稳定性,使用这些标记物的 MSI 病例显示 hMLH1 启动子异常。因此,这些标记物可用于识别错配修复表型。在更大的样本上验证后,这两个标记物可能有助于筛选与早期癌症相关的变化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验